Company / Operating Income per Share
PTC Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$11.16
FY2025
5-year range
-$6.10 / $11.16
FY2021-FY2025
Trend
+379.2%
vs FY2024
Sector context
#6 of 201
Health Care
What the data says
Operating Income per Share changed +379% YoY in FY2025, a notable deviation from the 9-year average annual change of +29%.
Based on SEC 10-K filings.
11.16 in FY2025. Top quartile in the Health Care sector.
Improved from $-6.01 to $11.16 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 201This company $11.16 Sector average -$3.23
▼
+445.0% above sector average
Key checks
Key Insights
- PTC Therapeutics, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 379.2% year-over-year.
- Ranks #6 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.16 | +379.2% |
| FY2024 | -$4.00 | +33.5% |
| FY2023 | -$6.01 | +1.4% |
| FY2022 | -$6.10 | -76.2% |
| FY2021 | -$3.46 | -85.2% |
| FY2020 | -$1.87 | +54.4% |
| FY2019 | -$4.10 | -47.4% |
| FY2018 | -$2.78 | -47.8% |
| FY2017 | -$1.88 | +51.7% |
| FY2016 | -$3.89 | +23.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026